Recurring chromosomal abnormalities in Non-Hodgkin's lymphoma: Biologic and clinical significance

Seminars in Hematology

Volumn 37, Issue 4, 2000, Pages 396-411

  Chaganti, R S K ^a   Nanjangud, Gouri ^a   Schmidt, Helmut ^a   Julie, Teruya Feldstein ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER GROWTH; CANCER INCIDENCE; CANCER MORTALITY; CARCINOGENESIS; CELL TRANSFORMATION; CHROMOSOME ABERRATION; CHROMOSOME TRANSLOCATION; CLINICAL FEATURE; CONFERENCE PAPER; CYTOGENETICS; GENE AMPLIFICATION; GENE DELETION; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC ASSOCIATION; HUMAN; MINIMAL RESIDUAL DISEASE; NATURAL KILLER CELL; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; RECURRENT DISEASE; SOMATIC MUTATION;

EID: 0033784294     PISSN: 00371963     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0037-1963(00)90019-2     Document Type: Conference Paper

References (117)

1. Monosomy 13 is associated with the transition of monoclonal gammopathy of undetermined significance to multiple myeloma. Intergroupe Francophone du Myelome
2. LAZ3 rearrangements in non-Hodgkin's lymphoma: Correlation with histology, immunophenotype, karyotype, and clinical outcome in 217 patients
3. Increased number of chromosomal imbalances and high-level DNA amplifications in mantle cell lymphoma are associated with blastoid variants
4. High incidence of chromosomal imbalances and gene amplifications in the classical follicular variant of follicle center lymphoma
5. t(11;14)-Positive mantle cell lymphomas exhibit complex karyotypes and share similarities with B-cell chronic lymphocytic leukemia
6. Gene amplification in non-Hodgkin's lymphoma
7. Cytogenetic studies on prolymphocytic leukemia. 1. B-cell prolymphocytic leukemia
8. A cytogenetic analysis of 280 patients with multiple myeloma and related disorders: Primary breakpoints and clinical correlations
9. The IgG Fc receptor, FcgammaRIIB, is a target for deregulation by chromosomal translocation in malignant lymphoma
10. Distribution and pattern of BCL-6 mutations throughout the spectrum of B-cell neoplasia
11. Involvement of BCL6 in chromosomal aberrations affecting band 3q27 in B-cell non-Hodgkin lymphoma
12. Deregulation of BCL6 in non-Hodgkin lymphoma by insertion of IGH sequences in complex translocations involving band 3q27
13. Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3
14. Recurrent immunoglobulin gene translocations identify distinct molecular subtypes of myeloma
15. Characterization of nonrandom chromosomal gains and losses in multiple myeloma by comparative genomic hybridization
16. Cytogenetic analysis of 363 consecutively ascertained diffuse large B-cell lymphomas
17. Hepatosplenic T-cell lymphoma: A distinct clinicopathologic entity of cytotoxic gamma delta T-cell origin
18. Atypical chronic lymphocytic leukaemia with t(11;14) (q13;q32): Karyotype evolution and prolymphocytic transformation
19. Cytogenetic profile of lymphoma of follicle mantle lineage: Correlation with clinicobiologic features
20. Human c-myc oncogene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells
21. Mechanism of activation and biological role of the c-myc oncogene in B-cell lymphomagenesis
22. Identification of genetic lesions associated with diffuse large-cell lymphoma
23. Molecular pathogenesis of B cell malignancy: The role of BCL-6
24. Bcl-1/cyclin D1 in malignant lymphoma
25. Trisomy 3 in marginal zone B-cell lymphoma: A study based on cytogenetic analysis and fluorescence in situ hybridization
26. Marginal zone B-cell lymphomas of different sites share similar cytogenetic and morphologic features
27. The apoptosis inhibitor gene API2 and a novel 18q gene, MLT, are recurrently rearranged in the t(11;18)(q21;q21) associated with mucosa-associated lymphoid tissue lymphomas
28. 11q deletions identify a new subset of B-cell chronic lymphocytic leukemia characterized by extensive nodal involvement and inferior prognosis
29. Chromosome aberrations in B-cell chronic lymphocytic leukemia: Reassessment based on molecular cytogenetic analysis
30. Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leukemia-lymphoma cells
31. BCL8, a novel gene involved in translocations affecting band 15q11-13 in diffuse large-cell lymphoma
32. MUC1 is activated in a B-cell lymphoma by the t(1;14)(q21;q32) translocation and is rearranged and amplified in B-cell lymphoma subsets
33. Cytogenetics and molecular genetics in multiple myeloma
34. Insertion of excised IgH switch sequences causes overexpression of cyclin D1 in a myeloma tumor cell
35. Deletions involving two distinct regions of 6q in B-cell non-Hodgkin lymphoma
36. Pathologic prognostic factors in diffuse aggressive non-Hodgkin's lymphoma
37. The incidence of trisomy 3 in splenic lymphoma with villous lymphocytes: A study by FISH
38. Hairy cell leukemia is characterized by clonal chromosome abnormalities clustered to specific regions
39. Oncogene activation by chromosome translocation in human malignancy
40. V(D)J recombinase activity in a subset of germinal center B lymphocytes
41. A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group
42. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee meeting - Airlie House, Virginia, November 1997
43. p53 Gene mutations and protein overexpression are associated with aggressive variants of mantle cell lymphomas
44. Treatment approaches to the low-grade lymphomas
45. REL proto-oncogene is frequently amplified in extranodal diffuse large cell lymphoma
46. The t(9;14)(p13;q32) chromosomal translocation associated with lymphoplasmacytoid lymphoma involves the PAX-5 gene
47. Deregulation of MUM1/IRF4 by chromosomal translocation in multiple myeloma
48. Cytogenetic evolution patterns in non-Hodgkin's lymphoma
49. Primary mediastinal (thymic) B-cell lymphoma is characterized by gains of chromosomal material including 9p and amplification of the REL gene
50. Cytogenetics in CLL and related disorders
51. Cloning and gene mapping of the chromosome 13q14 region deleted in chronic lymphocytic leukemia
52. Chromosome abnormalities in adult T-cell leukemia/lymphoma: A Karyo-type Review Committee report
53. Stem cell transplantation for indolent lymphoma
54. Clinical relevance of BCL2, BCL6, and MYC rearrangements in diffuse large B-cell lymphoma
55. Follicular lymphoma with t(8;14)(q24;q32): A distinct clinical and molecular subset of t(8;14)-bearing lymphomas
56. A new fusion gene TPM3-ALK in anaplastic large cell lymphoma created by a(1;2)(q25;p23) translocation
57. Frequent deletions at 11q23 and 13q14 in B cell prolymphocytic leukemia (B-PLL)
58. Rearrangements of the BCL6 gene in diffuse large cell non-Hodgkin's lymphoma
59. Abnormalities of chromosomes 8, 11, 14, and X in T-prolymphocytic leukemia studied by fluorescence in situ hybridization
60. 7q31-32 allelic loss is a frequent finding in splenic marginal zone lymphoma
61. Identification of a transcriptional unit adjacent to the breakpoint in the 14;19 translocation of chronic lymphocytic leukemia
62. t(14;19)/BCL3 rearrangements in lymphoproliferative disorders: A review of 23 cases
63. + anaplastic large cell lymphoma
64. DNA copy number changes in diffuse large B-cell lymphoma - Comparative genomic hybridization study
65. Gain of 3q and deletion of 11q22 are frequent aberrations in mantle cell lymphoma
66. Molecular characterization of deletion at 11q22.1-23.3 in mantle cell lymphoma
67. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma
68. B cell lymphoma-associated chromosomal translocation involves candidate oncogene lyt-10, homologous to NF-kappa B p50
69. Chromosomal aberrations in non-Hodgkin's lymphoma. Biologic and clinical correlations
70. Cytogenetic analysis of 434 consecutively ascertained specimens of non-Hodgkin's lymphoma: Correlations between recurrent aberrations, histology, and exposure to cytotoxic treatment
71. t(9;14)(p13;q32) Denotes a subset of low-grade non-Hodgkin's lymphoma with plasmacytoid differentiation
72. 6q Deletions define distinct clinico-pathologic subsets of non-Hodgkin's lymphoma
73. Rearrangement of the bcl-6 gene as a prognostic marker in diffuse large-cell lymphoma
74. Clinical and morphologic features of B-cell small lymphocytic lymphoma with del(6)(q21q23)
75. Del(7)(q32) is associated with a subset of small lymphocytic lymphoma with plasmacytoid features
76. The t(11;18) (q21;q21) chromosome translocation is a frequent and specific aberration in low-grade but not high-grade malignant non-Hodgkin's lymphomas of the mucosa-associated lymphoid tissue (MALT-) type
77. BCL-6 mutations in normal germinal center B cells: Evidence of somatic hypermutation acting outside Ig loci
78. Prognostic factors in multiple myeloma
79. Multicolor spectral karyotyping identifies new recurring breakpoints and translocations in multiple myeloma
80. Chromosomal and gene amplification in diffuse large B-cell lymphoma
81. Somatic point mutations in the translocated bcl-2 genes of non-Hodgkin's lymphomas and lymphocytic leukemias: Implications for mechanisms of tumor progression
82. Cytogenetic analysis of 124 prospectively ascertained male germ cell tumors
83. The clinical relevance of t(14;18)/BCL-2 rearrangement and DEL 6q in diffuse large cell lymphoma and immunoblastic lymphoma
84. t(1;2)(q21;p23) And t(2;3)(p23;q21): Two novel variant translocations of the t(2;5)(p23;q35) in anaplastic large cell lymphoma
85. Exclusive detection of the t(11;18)(q21;q21) in extranodal marginal zone B cell lymphomas (MZBL) of MALT type in contrast to other MZBL and extranodal large B cell lymphomas
86. p53 Mutation is associated with progression in follicular lymphomas
87. Cytogenetic findings in peripheral T-cell lymphomas as a basis for distinguishing low-grade and high-grade lymphomas
88. Detection of aberrant clones in nearly all cases of angioimmunoblastic lymphadenopathy with dysproteinemia-type T-cell lymphoma by combined interphase and metaphase cytogenetics
89. Significance of cytogenetic findings for the clinical outcome in patients with T-cell lymphoma of angioimmunoblastic lymphadenopathy type
90. Chromosomal abnormalities in untreated patients with non-Hodgkin's lymphoma: Associations with histology, clinical characteristics, and treatment outcome. The Nebraska Lymphoma Study Group
91. Oncogene amplification in solid tumors
92. Chromosome 13 deletion in myeloma
93. Mutation of BCL-6 gene in normal B cells by the process of somatic hypermutation of Ig genes
94. Anaplastic large cell lymphoma: A clinicopathologic analysis
95. Frequent involvement of chromosomes 1, 3, 7 and 8 in splenic marginal zone B-cell lymphoma
96. Recurrent abnormalities of chromosome bands 10q23-25 in non-Hodgkin's lymphoma
97. Clinical significance of bcl-2-MBR gene rearrangement and protein expression in diffuse large-cell non-Hodgkin's lymphoma: An analysis of 83 cases
98. Recurring structural chromosome abnormalities in peripheral blood lymphocytes of patients with mycosis fungoides/Sezary syndrome
99. Prognostic value of chromosomal abnormalities in follicular lymphoma
100. Genetic analysis of splenic lymphoma with villous lymphocytes: A Groupe Francais d'Hematologie Cellulaire (GFHC) study
101. Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation
102. Molecular cloning of the chromosomal breakpoint of B-cell lymphomas and leukemias with the t(11;14) chromosome translocation
103. p53 Gene deletion and trisomy 12 in hairy cell leukemia and its variant
104. Rearrangements of bcl-6, bcl-2, c-myc and 6q deletion in B-diffuse large-cell lymphoma: Clinical relevance in 71 patients
105. A novel nested-PCR strategy for the detection of rearranged immunoglobulin heavy-chain genes in B cell tumors
106. Epidemiology of non-Hodgkin's lymphoma: Recent findings regarding an emerging epidemic
107. Occurrence of the t(2;5)(p23;q35) in non-Hodgkin's lymphoma
108. Sequential analysis of 43 patients with non-Hodgkin's lymphoma: Clinical correlations with cytogenetic, histologic, immunophenotyping, and molecular studies
109. Bcl10 is involved in t(1;14)(p22;q32) of MALT B cell lymphoma and mutated in multiple tumor types
110. Molecular cloning of translocation t(1;14)(q21;q32) defines a novel gene (BCL9) at chromosome 1q21
111. The cryptic inv(2)(p23q35) defines a new molecular genetic subtype of ALK-positive anaplastic large-cell lymphoma
112. Cytogenetic abnormalities in natural killer cell lymphoma/leukaemia - Is there a consistent pattern?
113. MYC rearrangements in histologically progressed follicular lymphomas
114. Alterations of a zinc finger-encoding gene, BCL-6, in diffuse large B-cell lymphoma
115. Molecular cloning of complex chromosomal translocation t(8;14;12)(q24.1;q32.3;q24.1) in a Burkitt lymphoma cell line defines a new gene (BCL7A) with homology to caldesmon